Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov 7;396(10261):1464-1465.
doi: 10.1016/S0140-6736(20)32010-9. Epub 2020 Oct 13.

First human efficacy study of a plant-derived influenza vaccine

John S Tregoning  1
Affiliations
Comment

First human efficacy study of a plant-derived influenza vaccine

John S Tregoning. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ward BJ, Makarkov A, Séguin A. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials. Lancet. 2020 doi: 10.1016/S0140-6736(20)32014-6. published online Oct 13. - DOI - PubMed
    1. Pebody R, Djennad A, Ellis J. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Euro Surveill. 2019;24 - PMC - PubMed
    1. Dunkle LM, Izikson R, Patriarca P. Efficacy of recombinant influenza vaccine in adults 50 years of age or older. N Engl J Med. 2017;376:2427–2436. - PubMed
    1. Izurieta HS, Chillarige Y, Kelman J. Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017–2018. J Infect Dis. 2019;220:1255–1264. - PubMed
    1. Barr IG, Donis RO, Katz JM. Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness. NPJ Vaccines. 2018;3:44. - PMC - PubMed

MeSH terms

Substances